Drug Database
Back to search

Netherlands· NL-729995466df7

Viramune 50 mg/5 ml Oral Suspension, suspensie voor oraal gebruik

A nevirapine product containing nevirapine 0,5-water, registered in Netherlands by Boehringer Ingelheim Pharma GmbH & Co. KG. The same ATC class is registered in 16 of our 19 countries.

ATC J05AG01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedViramune 50 mg/5 ml Oral Suspension, …ATCJ05AG01REGISTER NO.NL-729995466df7PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nevirapine 0,5-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nevirapine is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AG01 (nevirapine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search nevirapine products by name

Nevirapine · ATC J05AG01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nevirapine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.81 in France to $7.77 in Switzerland — a ×2.0 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Nevirapine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$7.77
  • FR France$3.81
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
NEVIRAPINE 0,5-WATER
Manufacturer
Boehringer Ingelheim Pharma GmbH & Co. KG
Country
Netherlands (NL)
ATC code
J05AG01
ATC class
Nevirapine
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/97/055

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

316 interactions on record for nevirapine.

Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nevirapine against other medicinesHow interaction checks work

Nevirapine · interactions on record

316 records

  • 26 severe
  • 220 moderate
  • 8 minor
  • 49 info

Most severe, free to view

  • DeflazacortH02AB13severe
  • BrigatinibL01ED04severe
  • LorlatinibL01ED05severe
  • CobimetinibL01EE02severe

13 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nevirapine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nevirapine products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Nevirapin Viatris
  • Belgium · Nevirapine Viatris
  • Germany · Nevirapin Abdi, Nevirapin Aurobindo
  • Denmark · Nevirapine Medical Valley, Nevirapine Viatris
  • Spain · Nevirapina Aurovitas, Nevirapina Kern Pharma
  • Finland · Nevirapine Viatris
  • France · Nevirapine Arrow Lab, Nevirapine Cristers
  • United Kingdom (Northern Ireland) · Nevirapine Accord, Nevirapine Accord Healthcare
  • Greece · Nevirapine Vocate
  • Iceland · Viramune
  • Italy · Nevirapina Aurobindo, Nevirapina Mylan
  • Liechtenstein · Viramune
  • Luxembourg · Nevirapine Viatris
  • Norway · Viramune
  • Portugal · Nevirapina Accord, Nevirapina Aurovitas
  • Romania · Nevirapina Accord, Nevirapină Accord
  • Sweden · Nevirapine Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c92bd2e7-9836-4c46-831e-5c18eb6d239b
GET /v1/drugs/c92bd2e7-9836-4c46-831e-5c18eb6d239b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/viramune-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Nevirapine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70529",
  "excipients": [
    "CARBOMEER 934P",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMHYDROXIDE (E 524)",
    "POLYSORBAAT 80 (E 433)",
    "PROPYLPARAHYDROXYBENZOAAT",
    "SACCHAROSE",
    "SORBITOL, VLOEIBAAR, KRISTALLISEERBAAR (E 420)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "NEVIRAPINE 0,5-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "1999/06/18",
  "procedure_number": "EMEA/H/C/000183",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/97/055",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about nevirapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console